Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Access to healthcare

Kenya to introduce better treatment for people living with HIV

Editor's pick
UNITAID
28 June 2017
HIV treatment for children & young people

HIV drug resistance becoming more common in Zambian infants

News
27 June 2017
Access to healthcare

Dolutegavir access in the Asia-Pacific region

Editor's pick
amfAR Treat Asia
27 June 2017
Side effects

Medicine information leaflets 'too scary', say experts

Editor's pick
BBC Health
20 June 2017
Bad science & bogus treatments

Top HIV expert is not donating to crowdfunding HIV vaccine campaign, says it's "Fake News"

Editor's pick
imstilljosh
17 June 2017
Resistance

HIV drug resistance testing not a priority for resource-limited settings, trial finds

News
14 June 2017
Adherence

SA's new HIV challenge: patients who believe they've been healed

Editor's pick
Citizen
13 June 2017
PrEP science

Long-acting Injectable Antiretrovirals for PrEP: Will the tail wag the drug?

Editor's pick
AVAC
9 June 2017
Global health targets

Study: 1 in 3 Patients Starts HIV Treatment Late in 10 Countries

Editor's pick
Voice of America
9 June 2017
Treatment for women

Meds May Impact Prenatal Screening in HIV+ Patients

Editor's pick
MedPage Today HIV/AIDS
8 June 2017
Resistance

Experts raise concerns over high HIV treatment failure in Kenya

Editor's pick
The Standard
6 June 2017
New & experimental HIV treatments

ViiV Healthcare Files Regulatory Submissions for First Two-Drug HIV Maintenance Regimen

Editor's pick
ViiV
2 June 2017
Changing treatment

HIV: A therapeutic advance for resource-limited settings

Editor's pick
Eurekalert Inf Dis
31 May 2017
Pharmaceutical industry

Gilead and GSK go head-to-head with similar HIV drug data

Editor's pick
Reuters
31 May 2017
New & experimental HIV treatments

Gilead’s Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for the Treatment of HIV-1 Meets Primary Endpoint in Four Phase 3 Studies

Editor's pick
Gilead press release
30 May 2017
Adherence

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

News
30 May 2017
Contraception

Taking Birth Control With HIV Treatment or PrEP Is Largely OK

Editor's pick
Poz
30 May 2017
HIV treatment

The Truth About HIV

Editor's pick
BBC iPlayer (UK only, available until 24 June)
26 May 2017
Money

Life insurance policyholders with HIV urged to review life cover term

Editor's pick
Professional Adviser
24 May 2017
Generic medicines

Unexpected side effects with generic abacavir – and potential for rare reactions to other generic ARVs

Editor's pick
HIV i-Base
23 May 2017
New & experimental HIV treatments

Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS® (raltegravir) 600 mg in the European Union

Editor's pick
Merck press release
22 May 2017
Pharmaceutical industry

CHMP recommends for approval generic version of Atripla

Editor's pick
EATG
22 May 2017
The search for an HIV prevention vaccine

Stock market models accurately predict changes in HIV over time

Editor's pick
Healio
18 May 2017
Harm reduction

Combining drug addiction treatment and perinatal HIV prevention leads to good outcomes in Kenya

News
18 May 2017